COVID-19 and liver diseaseJean-François Dufour, Thomas Marjot, Chiara Becchetti, Herbert Tilg
14 June 2022
Gut microbiota changes are detected in asymptomatic very young children with SARS-CoV-2 infectionLydia Nashed, Jyoti Mani, Sahel Hazrati, David B Stern, Poorani Subramanian, Lisa Mattei, Kyle Bittinger, Weiming Hu, Shira Levy, George L Maxwell, Suchitra K Hourigan
8 February 2022
Impact of pre-procedural testing on SARS-CoV-2 transmission to endoscopy staffAlexander Hann, Sven Flemming, Stanislaus Reimer, Kaja Groneberg, Theodor Kudlich, Christoph-Thomas Germer, Alexander Meining
7 July 2022
Primary biliary cholangitis and SARS-CoV-2 infection: incidence, susceptibility and outcomesJavier Ampuero, Ana Lucena, Manuel Hernández-Guerra, Isabel Moreno-Moraleda, Juan Arenas, Isabel Conde, Laura Muñoz, Lidia Canillas, Edgar Fernandez, Raisa Quiñones, Miguel Angel Simon, Elena Gómez-Dominguez, Maria Luisa Gutierrez, Conrado Fernandez-Rodriguez, Maria Jose Domper-ArnalSee the full list of authors
7 December 2021
Antibody response to the BNT162b2 SARS-CoV-2 vaccine in paediatric patients with inflammatory bowel disease treated with anti-TNF therapyZahra Jama Shire, Frederic Reicherz, Sally Lawrence, Harjeev Sudan, Liam Golding, Abdelilah Majdoubi, Paul N Levett, Pascal M Lavoie, Kevan Jacobson
23 November 2021
Combination therapy of infliximab and thiopurines, but not monotherapy with infliximab or vedolizumab, is associated with attenuated IgA and neutralisation responses to SARS-CoV-2 in inflammatory bowel diseaseJudith Wellens, Matthew Edmans, Uri Obolski, Colleen GC McGregor, Peter Simmonds, Marc Turner, Lisa Jarvis, Donal Skelly, Susanna Dunachie, Eleanor Barnes, David W Eyre, Jean-Frederic Colombel, Serre-Yu Wong, Paul Klenerman, James O LindsaySee the full list of authors
15 December 2021
Risk of adverse events and reported clinical relapse after COVID-19 vaccination in patients with IBDRosanna Cannatelli, Francesca Ferretti, Stefania Carmagnola, Irene Maria Bambina Bergna, Maria Camilla Monico, Giovanni Maconi, Sandro Ardizzone
24 November 2021
Clinical characteristics, hospitalisation and mortality rates of COVID-19 among patients with coeliac disease in the USA: a multicentre network studyEmad Mansoor, Muhammed Mustafa Alikhan, Jaime Abraham Perez, Kayla Schlick, Mohannad Abou Saleh, Alberto Rubio-Tapia
11 November 2021
SARS-CoV-2 infection is associated with an increased risk of idiopathic acute pancreatitis but not pancreatic exocrine insufficiency or diabetes: long-term results of the COVIDPAN studyManu Nayar, Chris Varghese, Aditya Kanwar, Ajith K Siriwardena, Ali Raza Haque, Altaf Awan, Anita Balakrishnan, Arab Rawashdeh, Bogdan Ivanov, Chetan Parmar, Christopher M Halloran, Clifford Caruana, Cynthia-Michelle Borg, Dhanny Gomez, Dimitrios DamaskosSee the full list of authors
11 November 2021
Prevalence and outcomes of acute pancreatitis in COVID-19: a meta-analysisFeng Yang, Yuting Huang, Tian Li, Yunting Fu, Chenyu Sun, Yecheng Xu, John Windsor, Deliang Fu
20 October 2021